Myeloma Study Days 29th June & 5th July 2017

For the last two years BOPA has successfully worked alongside Amgen to deliver Myeloma study days featuring the excellent Elaine Vickers who can really bring the science of novel agents life, the day will also feature clinical updates from leading local clinicians.  
 
The good news is the event organisers, Amgen, are able to make the days free for BOPA members.  It’s also worth noting that the study days are non-promotional educational events so the speakers will be covering all new drug developments in myeloma.  The feedback from last year’s events was excellent so it’s definitely one for the diary.

Look out for emails with details of how to register for the Sheffield study day on 29th June 2017 and the London study day on 5th July 2017.

Steve Williamson, BOPA chair

Latest News

By BOPA Committee on 26th November 2024

ISOPP CAPhO Symposium 2025 – Register Now!

Join the International Society of Oncology Pharmacy Practitioners and the Canadian Association of Pharmacy Oncology for leading edge education to advance your oncology pharmacy practice and knowledge! The ISOPP CAPhO Symposium 2025 will take…

Read article
By BOPA Executive Committee on 25th November 2024

Announcement: New Specialist pancreatic cancer E-Learning Resource Now Available

Announcement: New Specialist pancreatic cancer E-Learning Resource Now Available We’re excited to announce that a new specialist e-learning resource has been added to our website! This invaluable resource, provided by…

Read article
By BOPA on 23rd November 2024

New Recordings NOW available

The recordings of the UK BMT Pharmacists Group Educational Meeting June 2024 is now available to watch via this link: UK BMT Pharmacists Group Educational Meeting Series (June 2024)  …

Read article
By BOPA Research Committee on 21st November 2024

National survey about the implementation of JBDS/UK chemo board guidelines on the management of glycaemia in people with cancer

National survey about the implementation of JBDS/UK chemo board guidelines on the management of glycaemia in people with cancer. The purpose is to understand some of the enablers and barriers…

Read article